Baird Medical Investment Holdings Limited (BDMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Baird Medical Investment Holdings Limited (BDMD) has a cash flow conversion efficiency ratio of -0.090x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.19 Million) by net assets ($35.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Baird Medical Investment Holdings Limite worth for the company's overall valuation and market capitalisation.
Baird Medical Investment Holdings Limited - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Baird Medical Investment Holdings Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Baird Medical Investment Holdings Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Baird Medical Investment Holdings Limited ranked by their cash flow conversion efficiency. Explore how high is Baird Medical Investment Holdings Limite's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
First Graphene Ltd
AU:FGR
|
-0.220x |
|
Urbanfund Corp
V:UFC
|
0.028x |
|
Sentien Printing Factory Co Ltd
TWO:8410
|
0.045x |
|
Carnival PLC
LSE:CCL
|
0.096x |
|
Compal Broadband Networks Inc
TW:6674
|
-0.187x |
|
Heimstaden AB Pfd.
ST:HEIM-PREF
|
0.008x |
|
K2A Knaust & Andersson Fastigheter AB (publ)
ST:K2A-B
|
-0.007x |
|
Digitalx Ltd
AU:DCC
|
-0.023x |
Annual Cash Flow Conversion Efficiency for Baird Medical Investment Holdings Limited (2019–2024)
The table below shows the annual cash flow conversion efficiency of Baird Medical Investment Holdings Limited from 2019 to 2024. View current stock price of Baird Medical Investment Holdings Limite for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $39.76 Million | $-6.31 Million | -0.159x | -455.86% |
| 2023-12-31 | $35.71 Million | $-1.02 Million | -0.029x | -251.52% |
| 2022-12-31 | $25.78 Million | $485.97K | 0.019x | -94.31% |
| 2021-12-31 | $15.86 Million | $5.26 Million | 0.331x | -42.65% |
| 2020-12-31 | $6.76 Million | $3.91 Million | 0.578x | +395.65% |
| 2019-12-31 | $-22.58 Million | $4.41 Million | -0.195x | -- |
About Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, in… Read more